Lunai Bioworks (LNAI) Other financing activities (2015 - 2021)
Lunai Bioworks (LNAI) recorded quarterly Other financing activities of $352429.0 in Q1 2021, down 1.94% quarter-over-quarter from $359391.0 in Q4 2020, and up 1354.46% on a YoY basis from $24230.9 in Q1 2020.
Lunai Bioworks (LNAI) Other financing activities (2015 - 2021) Analysis & Trends
Lunai Bioworks' Other financing activities history runs 5 years deep, the most recent figure standing at $352429.0 for Q1 2021.
- In Q1 2021, Other financing activities rose 1354.46% year-over-year to $352429.0; the TTM figure through Mar 2021 stood at $1.0 million (up 18.99% YoY), while the FY2014 annual figure was $89360.0, up 33.37% from the prior year.
- Other financing activities was $352429.0 for Q1 2021 at Lunai Bioworks, down from $359391.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.8 million in Q4 2018 to a low of -$28094.0 in Q1 2020.
- Historically, Other financing activities has averaged $412545.8 across 4 years, with a median of $326156.0 in 2020.
- The sharpest annual moves came in 2020 and 2021: Other financing activities tumbled 129.04% in 2020, then soared 1354.46% in 2021.
- A 4-year view of Other financing activities shows it stood at $1.8 million in 2018, then sank by 69.32% to $546061.0 in 2019, then plunged by 34.18% to $359391.0 in 2020, then declined by 1.94% to $352429.0 in 2021.
- The last three Other financing activities figures came in at $352429.0 (Q1 2021), $359391.0 (Q4 2020), and $326156.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 352,429.00 |
| Mar 31, 2021 | 352,429.00 |
| Dec 31, 2020 | 359,391.00 |
| Dec 31, 2020 | 359,391.00 |
| Sep 30, 2020 | 326,156.00 |
| Sep 30, 2020 | 326,156.00 |
| Mar 31, 2020 | -28,094.00 |
| Mar 31, 2020 | -28,094.00 |
| Dec 31, 2019 | 546,061.00 |
| Dec 31, 2019 | 546,061.00 |
| Sep 30, 2019 | 234,010.00 |
| Sep 30, 2019 | 234,010.00 |
| Mar 31, 2019 | 96,733.00 |
| Mar 31, 2019 | 96,733.00 |
| Dec 31, 2018 | 1.78 Mn |
| Dec 31, 2018 | 1.78 Mn |
| Sep 30, 2018 | 46,166.00 |
| Sep 30, 2018 | 46,166.00 |
| Mar 31, 2015 | 89,360.00 |
| Mar 31, 2015 | 89,360.00 |